Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05746143 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 31, 2026 to Jan 31, 2029
    • Study completion date: Dec 31, 2027 to Dec 31, 2030
    v3
  2. Phase: Not applicable to Phase 4
    • Primary completion date: Dec 31, 2023 to Jan 31, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2027
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.
Trial Details
NCT Number NCT05746143
Lead Sponsor University of Southern California
Conditions
(from sponsor)		 Spine Fusion, Lumbar Spine Degeneration, Pain, Postoperative, Lumbar Spine Spondylosis
Related terms Postoperative Pain
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov